Cargando…
Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335104/ https://www.ncbi.nlm.nih.gov/pubmed/35354256 http://dx.doi.org/10.3324/haematol.2022.280652 |
_version_ | 1784759261411147776 |
---|---|
author | Loffredo, Lorenzo Di Castelnuovo, Augusto Chiariello, Giovanni Alfonso Pignatelli, Pasquale Violi, Francesco |
author_facet | Loffredo, Lorenzo Di Castelnuovo, Augusto Chiariello, Giovanni Alfonso Pignatelli, Pasquale Violi, Francesco |
author_sort | Loffredo, Lorenzo |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9335104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-93351042022-08-26 Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis Loffredo, Lorenzo Di Castelnuovo, Augusto Chiariello, Giovanni Alfonso Pignatelli, Pasquale Violi, Francesco Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-03-31 /pmc/articles/PMC9335104/ /pubmed/35354256 http://dx.doi.org/10.3324/haematol.2022.280652 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letter to the Editor Loffredo, Lorenzo Di Castelnuovo, Augusto Chiariello, Giovanni Alfonso Pignatelli, Pasquale Violi, Francesco Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis |
title | Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis |
title_full | Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis |
title_fullStr | Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis |
title_full_unstemmed | Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis |
title_short | Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis |
title_sort | full versus prophylactic-intermediate doses of anticoagulants in covid-19: a meta-analysis |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335104/ https://www.ncbi.nlm.nih.gov/pubmed/35354256 http://dx.doi.org/10.3324/haematol.2022.280652 |
work_keys_str_mv | AT loffredolorenzo fullversusprophylacticintermediatedosesofanticoagulantsincovid19ametaanalysis AT dicastelnuovoaugusto fullversusprophylacticintermediatedosesofanticoagulantsincovid19ametaanalysis AT chiariellogiovannialfonso fullversusprophylacticintermediatedosesofanticoagulantsincovid19ametaanalysis AT pignatellipasquale fullversusprophylacticintermediatedosesofanticoagulantsincovid19ametaanalysis AT violifrancesco fullversusprophylacticintermediatedosesofanticoagulantsincovid19ametaanalysis |